Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) · 15 hours ago
Commercial Strategy & Portfolio Management Lead
Arcutis Biotherapeutics, Inc. is a pioneering medical dermatology company dedicated to revolutionizing the treatment of serious skin diseases. The Commercial Strategy & Portfolio Management Lead will serve as a strategic advisor to the Chief Commercial Officer, focusing on commercial strategy, investment planning, and cross-functional execution to drive alignment and disciplined delivery of commercial priorities.
BiopharmaBiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics
Responsibilities
Partner closely with the CCO to provide strategic analyses, recommendations, and decision support on commercial priorities
Translate leadership objectives into clear plans, milestones, and accountability across the Commercial organization
Prepare executive-level materials for leadership meetings, operating reviews, and enterprise or Board updates
Facilitate Commercial leadership team meetings and cross-functional forums to drive alignment, decision-making, and execution
Monitor progress against key initiatives, proactively identifying risks, gaps, and interdependencies and recommending mitigation strategies
Lead commercial investment planning, forecasting, and portfolio governance to ensure resources are aligned with strategic priorities and growth objectives
Partner with Commercial leaders to evaluate trade-offs, conduct scenario planning, and optimize resource allocation across brands and initiatives
Drive transparency and accountability through performance reporting, insights, and metrics tied to commercial outcomes and ROI
Support long-range planning, launch readiness, and future-state operating model evolution as the organization scales
Own end-to-end Commercial budget oversight, tracking, and reporting in close collaboration with Finance
Establish and manage a best-in-class agency and vendor management framework, including oversight of SOWs, POs, invoicing, contract routing, and spend governance
Partner with Procurement, Legal, and Finance to ensure compliance, efficiency, and scalability of vendor operations
Ensure disciplined governance of commercial spend while enabling agility and speed of execution
Act as a central point of coordination across Commercial, Finance, Market Access, Medical, Legal, and Procurement
Enable effective execution by driving clarity on priorities, decisions, and ownership across stakeholders
Identify opportunities to improve operational effectiveness, streamline processes, and maximize the impact of commercial investments
This position has no internal supervisory responsibilities but may oversee external agency relationships. The position will also be responsible for the management, update and report generation from various Commercial Organization systems
Qualification
Required
Bachelor's degree in Finance, Business, Marketing, or related field
10+ years of experience in commercial operations, finance, marketing operations, or vendor/budget management
Biopharma or healthcare experience strongly preferred
Proven ability to manage complex budgets and financial planning processes with high accuracy and attention to detail
Experience developing and managing SOWs, POs, vendor contracts, and agency relationships
Strong analytical, organizational, and problem-solving skills with the ability to translate financial information into actionable insights
Excellent communication and interpersonal skills; comfortable influencing across teams and levels
Advanced proficiency in Excel and financial tracking tools; familiarity with SAP/Oracle/Workday or similar systems a plus
Demonstrated ability to work in a fast-paced, evolving environment while managing multiple priorities and deadlines
Travel up to 30%
Preferred
MBA or other related advanced degree preferred
Company
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology.
Funding
Current Stage
Public CompanyTotal Funding
$833.5MKey Investors
SLR Capital PartnersHBM Healthcare InvestmentsOrbiMed
2024-02-28Post Ipo Equity· $150M
2023-10-19Post Ipo Equity· $100M
2022-08-02Post Ipo Equity
Leadership Team
Recent News
The Motley Fool
2025-12-14
2025-11-22
Company data provided by crunchbase